HCM HUTCHMED (China) Limited - American Depositary Shares
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Mar 5, 2026
$14,20
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$9,77minimo 52 sett.
$16,40massimo 52 sett.
Capitalizzazione di Mercato
$12.39B
P/E
27.3
EPS
$0.52
Ricavi
$549M
i tuoi badge
Intervallo 52 sett.
$10–$16
Rating Analisti
BUY
Prezzo Obiettivo
$22
P/E
27.3
ROE
45.7%
Margine di Profitto Netto
83.3%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
HCM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$14.20
Capitalizzazione di Mercato
$12.39B
P/E
27.3
EPS
$0.52
Ricavi
$549M
ROE
45.7%
D/E Debito/Patrimonio
0.1
Intervallo 52 sett.
$10–$16
HCM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$549M2016-12-31 → 2025-12-31
EPS$0.522016-12-31 → 2025-12-31
Flusso di cassa libero$-79M2016-12-31 → 2025-12-31
Margine netto83.3%2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | HCM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | 27.3media 5 anni ≈72.4 | ≈72.4 | · | · | |
| P/S | 22.6media 5 anni ≈35.0 | ≈35.0 | · | · | |
| P/B | 10.0media 5 anni ≈19.8 | ≈19.8 | · | · | |
| EV / EBITDA | -430.8media 5 anni ≈-67.2 | ≈-67.2 | · | · | |
| Price / FCF (Prezzo / FCF) | -157.2media 5 anni ≈-192.5 | ≈-192.5 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -191.6media 5 anni ≈4993.4 | ≈4993.4 | · | · | |
| EV / Revenue (EV / Ricavi) | 20.3media 5 anni ≈33.3 | ≈33.3 | · | · | |
| EV / FCF | -141.3media 5 anni ≈-180.5 | ≈-180.5 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 10.1media 5 anni ≈19.9 | ≈19.9 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | HCM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -7.1%media 5 anni ≈-39.9% | ≈-39.9% | · | · | |
| EBITDA Margin (Margine EBITDA) | -4.7%media 5 anni ≈-38.1% | ≈-38.1% | · | · | |
| Pretax Margin (Margine ante imposte) | 90.9%media 5 anni ≈-11.8% | ≈-11.8% | · | · | |
| Net Profit Margin (Margine di Profitto Netto) | 83.3%media 5 anni ≈-7.6% | ≈-7.6% | · | · | |
| ROA | 30.2%media 5 anni ≈-1.3% | ≈-1.3% | · | · | |
| ROE | 45.7%media 5 anni ≈-1.2% | ≈-1.2% | · | · | |
| ROIC | -2.5%media 5 anni ≈-27.5% | ≈-27.5% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | HCM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debt / Equity (Debito / Patrimonio Netto) | 0.1media 5 anni ≈0.1 | ≈0.1 | · | · | |
| Current Ratio (Rapporto corrente) | 5.0media 5 anni ≈3.4 | ≈3.4 | · | · | |
| Quick Ratio | 4.7media 5 anni ≈3.1 | ≈3.1 | · | · | |
| Long-Term Debt / Equity (Debito a lungo termine / Patrimonio netto) | 0.1media 5 anni ≈0.1 | ≈0.1 | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | HCM | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.4media 5 anni ≈0.5 | ≈0.5 | · | · | |
| Inventory Turnover (Rotazione delle scorte) | 7.3 | · | · | · | |
| Receivables Turnover (Rotazione dei crediti) | 3.9media 5 anni ≈5.3 | ≈5.3 | · | · | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$306.4K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
95.6%
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2023 | $0.19 | $-0.38 | 149.9% | |
| 31 Dicembre 2021 | $-0.26 | $-1.06 | 75.6% | |
| 30 Giugno 2021 | $-0.14 | $-0.77 | 81.9% | |
| 31 Dicembre 2020 | $-0.11 | $-0.44 | 75.2% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | $178M | $87M | |
| Cost of Revenue | $336M | $349M | $384M | $311M | · | · | · | · | $170M | $149M | $105M | $53M | |
| R&D Expense | $148M | $212M | $302M | $387M | $299M | $175M | $138M | $114M | $76M | $67M | $47M | $30M | |
| SG&A Expense | $67M | $64M | $80M | $92M | $89M | $50M | $39M | $31M | $24M | $22M | $20M | $13M | |
| Operating Expenses | $588M | $674M | $820M | $834M | $684M | $425M | $351M | $307M | $295M | $263M | $188M | $106M | |
| Operating Income | $-39M | $-44M | $18M | $-408M | $-328M | $-197M | $-146M | $-93M | $-53M | $-47M | $-10M | $-18M | |
| Interest Expense | · | · | $759.0K | $652.0K | $592.0K | $787.0K | $1M | $1M | $1M | $2M | $1M | $2M | |
| Interest Income | $50M | $40M | $36M | $10M | $2M | $3M | $5M | $6M | $1M | $502.0K | $451.0K | $559.0K | |
| Other Non-op | $61M | $43M | $40M | $-3M | $-9M | $7M | $5M | $6M | $-119.0K | $-659.0K | $-769.0K | $-761.0K | |
| Pretax Income | $499M | $-1M | $58M | $-410M | $-216M | $-190M | $-141M | $-87M | $-54M | $-47M | $-11M | $-3M | |
| Income Tax | $64M | $7M | $5M | $-283.0K | $12M | $5M | $3M | $4M | $3M | $4M | $2M | $1M | |
| Net Income | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | $8M | $-7M | |
| EPS (Basic) | $0.53 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-0.11 | $-0.04 | $0.20 | $-0.64 | $-0.62 | |
| EPS (Diluted) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | $-0.64 | $-0.62 | |
| Shares (Basic) | 858,276,608 | 855,351,683 | 849,654,296 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 664,263,820 | 617,171,710 | 59,715,173 | 54,659,315 | 52,563,387 | |
| Shares (Diluted) | 872,891,120 | 872,829,129 | 869,196,348 | 847,143,540 | 792,684,524 | 697,931,437 | 665,683,145 | 66,426,382 | 61,717,171 | 59,971,050 | 54,659,315 | 52,563,387 | |
| EBITDA | $-26M | $-31M | $27M | $-399M | $-321M | $-191M | $-141M | $-89M | $-51M | $-44M | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $71M | $154M | $284M | $313M | $378M | $236M | $121M | $86M | $85M | $79M | $32M | $39M | |
| Short-term Investments | $1.30B | $682M | $603M | $318M | $634M | $200M | $96M | $215M | $273M | $24M | $0 | · | |
| Receivables | $127M | $156M | $117M | $98M | $84M | $48M | $41M | $40M | $38M | $41M | $33M | · | |
| Inventory | $41M | $50M | $50M | $57M | $36M | $20M | $16M | $12M | $12M | $13M | $10M | · | |
| Prepaid Expense | $8M | $8M | $7M | $22M | $14M | $7M | $4M | $4M | $3M | $699.0K | · | · | |
| Current Assets | $1.57B | $1.07B | $1.10B | $840M | $1.21B | $531M | $317M | $371M | $432M | $167M | $90M | · | |
| PP&E (Net) | $95M | $92M | $100M | $76M | $41M | $24M | $21M | $17M | $14M | $10M | $9M | · | |
| PP&E (Gross) | $168M | $152M | $146M | $113M | $74M | $50M | $44M | $36M | $32M | $24M | $22M | · | |
| Accum. Depreciation | · | · | · | $37M | $33M | $26M | $23M | $20M | $17M | $14M | $13M | $13M | |
| Goodwill | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $9M | · | $21.0K | $85.0K | $163.0K | $227.0K | $275.0K | $347.0K | $430.0K | $469.0K | $571.0K | · | |
| Other Non-current Assets | $20M | $12M | $15M | $16M | $22M | $20M | $6M | · | · | · | · | · | |
| Total Assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Accounts Payable | $46M | $43M | $36M | $71M | $41M | $32M | $24M | $26M | $24M | $36M | $21M | · | |
| Short-term Debt | $25M | $23M | $31M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $316M | $377M | $403M | $354M | $312M | $158M | $113M | $85M | $105M | $95M | $81M | · | |
| Capital Leases | $2M | $4M | $3M | $5M | $7M | $6M | $3M | · | · | · | · | · | |
| Deferred Tax | $255.0K | $3M | $1M | $3M | $3M | $5M | $3M | · | $4M | $4M | $3M | · | |
| Other Non-current Liabilities | · | $11M | $11M | $12M | $12M | $9M | $6M | $2M | $1M | $8M | $10M | · | |
| Total Liabilities | $502M | $502M | $536M | $393M | $333M | $205M | $152M | $120M | $113M | $138M | $127M | · | |
| Long-term Debt | $93M | $83M | $79M | $18M | · | · | · | $27M | $30M | $47M | $50M | · | |
| Total Debt | $118M | $106M | $110M | $18M | $27M | $27M | $27M | $27M | $30M | $27M | · | · | |
| Common Stock | $87M | $87M | $87M | $86M | $86M | $73M | $67M | $67M | $66M | $61M | $57M | · | |
| Retained Earnings | $-379M | $-833M | $-871M | $-971M | $-610M | $-416M | $-290M | $-183M | $-107M | $-80M | $-92M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $2M | $2M | · | |
| AOCI | $-5M | $-12M | $-8M | $-2M | $6M | $4M | $-4M | $-243.0K | $5M | $-4M | $5M | · | |
| Stockholders' Equity | $1.24B | $760M | $731M | $610M | $987M | $484M | $288M | $389M | $462M | $184M | $83M | · | |
| Liabilities + Equity | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B | $724M | $465M | $532M | $598M | $342M | $230M | · | |
| Shares Outstanding | 872,328,000 | 871,601,000 | 871,256,000 | 864,775,000 | 864,531,000 | 727,722,000 | 666,906,000 | 666,577,000 | 664,470,000 | 607,058,000 | 56,533,000 | 53,076,000 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $8M | $9M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Deferred Tax | $-118.0K | $5M | $2M | $-4M | $-5M | $3M | $2M | $2M | $2M | $3M | $1M | · | |
| Other Non-cash | $-596M | $-117M | $179M | $146M | $20M | $84M | $35M | $44M | $-1M | $-24M | · | · | |
| Operating Cash Flow | $-65M | $497.0K | $219M | $-269M | $-204M | $-62M | $-81M | $-33M | $-9M | $-10M | $-9M | $8M | |
| CapEx | $14M | $18M | $33M | $37M | $16M | $8M | $9M | $6M | $5M | $4M | $3M | $4M | |
| Investing Cash Flow | $-29M | $-96M | $-291M | $297M | $-306M | $-125M | $119M | $44M | $-261M | $-34M | $9M | $-15M | |
| Stock Issued | $2M | $790.0K | $5M | $174.0K | $717M | $319M | $251.0K | $4M | $302M | $111M | $1M | $3M | |
| Stock Repurchased | · | $36M | $9M | $48M | $27M | $13M | $346.0K | $5M | $1M | $604.0K | $2M | · | |
| Net Stock Activity | $2M | $-35M | $-4M | $-48M | $690M | $306M | $-95.0K | $-2M | $300M | $110M | · | · | |
| Financing Cash Flow | $8M | $-31M | $49M | $-83M | $650M | $296M | $-1M | $-8M | $273M | $92M | $-5M | $-641.0K | |
| Net Change in Cash | $-83M | $-130M | $-30M | $-64M | $142M | $114M | $35M | $771.0K | $6M | $47M | $-7M | $-8M | |
| Taxes Paid | $62M | $4M | $4M | $19M | $5M | $6M | $3M | $4M | $4M | $3M | $510.0K | $-908.0K | |
| Free Cash Flow | $-79M | $-17M | $187M | $-305M | $-221M | $-70M | $-89M | $-39M | $-14M | $-14M | · | · | |
| Levered FCF | · | · | $186M | $-306M | $-221M | $-71M | $-91M | $-40M | $-16M | $-15M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% | -86.3% | -71.5% | -43.3% | -22.1% | -21.6% | · | · | |
| Net Margin | 83.3% | 6.0% | 12.0% | -84.6% | -54.7% | -55.1% | -51.7% | -34.9% | -11.1% | 5.4% | · | · | |
| Pretax Margin | 90.9% | -0.18% | 7.0% | -96.2% | -60.6% | -83.2% | -68.9% | -40.5% | -22.2% | 9.5% | · | · | |
| EBITDA Margin | -4.7% | -5.0% | 3.2% | -93.6% | -90.2% | -83.6% | -69.0% | -41.6% | -21.1% | -20.5% | · | · | |
| ROA | 30.2% | 2.9% | 8.7% | -30.0% | -18.6% | -21.1% | -21.3% | -13.2% | -5.7% | 4.1% | · | · | |
| ROE | 45.7% | 5.1% | 15.0% | -45.2% | -26.5% | -32.6% | -31.3% | -17.6% | -8.3% | 8.7% | · | · | |
| ROIC | -2.5% | -37.8% | 2.0% | -64.8% | -34.2% | -39.5% | -47.6% | -23.3% | -11.5% | -17.4% | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 | 3.4 | 2.8 | 4.3 | 4.1 | 1.8 | · | · | |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 | 3.0 | 2.3 | 4.0 | 3.8 | 1.5 | · | · | |
| Debt / Equity | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Interest Coverage | · | · | 24.2 | -625.3 | -554.6 | -249.9 | -142.1 | -91.8 | -36.7 | -28.6 | · | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.5 | 0.7 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.8 | · | · | |
| Inventory Turnover | 7.3 | 6.9 | · | · | · | · | · | · | 13.8 | 13.3 | · | · | |
| Receivables Turnover | 3.9 | 4.6 | 7.8 | 4.7 | 5.4 | 5.2 | 5.0 | 5.4 | 6.1 | 5.8 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $0.87 | $0.84 | $0.71 | $1.14 | $0.67 | $0.43 | $5.84 | $6.95 | $3.04 | · | · | |
| Revenue / Share | $0.63 | $0.72 | $0.96 | $0.50 | $0.45 | · | · | $3.22 | $3.91 | $3.60 | · | · | |
| Cash Flow / Share | $-0.07 | $0.00 | $0.25 | $-0.32 | $-0.26 | · | · | $-0.49 | $-0.14 | $-0.16 | · | · | |
| Cash / Share | $0.08 | $0.18 | $0.33 | $0.36 | $0.44 | $0.32 | $0.18 | $1.29 | $1.28 | $1.31 | · | · | |
| EPS (TTM) | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 | $-0.18 | $-0.16 | $-1.13 | $-0.43 | $0.20 | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $549M | $630M | $838M | $426M | $356M | $228M | $205M | $214M | $241M | $216M | · | · | |
| Net Income TTM | $457M | $38M | $101M | $-361M | $-195M | $-126M | $-106M | $-75M | $-27M | $12M | · | · | |
| Market Cap | $11.63B | $12.56B | $15.78B | $12.78B | $30.33B | $23.30B | $16.72B | $1.54B | $2.62B | $824M | · | · | |
| Enterprise Value | $10.38B | $11.83B | $15.00B | $12.17B | $29.34B | $22.89B | $16.53B | $1.26B | $2.29B | $747M | · | · | |
| P/E | 25.6 | 360.2 | 150.9 | -34.4 | -140.3 | -177.9 | -156.7 | -20.4 | -91.7 | 67.8 | · | · | |
| P/S | 21.2 | 19.9 | 18.8 | 30.0 | 85.2 | 102.2 | 81.6 | 7.2 | 10.9 | 3.8 | · | · | |
| P/B | 9.4 | 16.5 | 21.6 | 20.9 | 30.7 | 48.1 | 58.1 | 4.0 | 5.7 | 4.5 | · | · | |
| P / Tangible Book | 9.5 | 16.6 | 21.7 | 21.1 | 30.8 | 48.5 | · | · | · | · | · | · | |
| P / Cash Flow | -179.8 | 25271.2 | 72.0 | -47.6 | -148.5 | -375.4 | -206.6 | -46.9 | -292.9 | -86.1 | · | · | |
| P / FCF | -147.6 | -720.3 | 84.5 | -41.9 | -137.5 | -332.8 | -186.9 | -39.3 | -187.6 | -59.3 | · | · | |
| EV / EBITDA | -401.5 | -377.2 | 564.4 | -30.5 | -91.4 | -120.1 | -116.9 | -14.2 | -45.1 | -16.8 | · | · | |
| EV / FCF | -131.7 | -678.5 | 80.4 | -39.9 | -133.0 | -327.0 | -184.7 | -32.3 | -164.1 | -53.8 | · | · | |
| EV / Revenue | 18.9 | 18.8 | 17.9 | 28.5 | 82.4 | 100.4 | 80.7 | 5.9 | 9.5 | 3.5 | · | · | |
| Earnings Yield | 3.9% | 0.28% | 0.66% | -2.9% | -0.71% | -0.56% | -0.64% | -4.9% | -1.1% | 1.5% | · | · |
Per Azione
| Metrica | Tendenza | Q4 2019 | Q4 2018 |
|---|---|---|---|
| EPS (TTM) | $-0.16 | $-1.13 |
Valutazione (TTM)
| Metrica | Tendenza | Q4 2019 | Q4 2018 |
|---|---|---|---|
| Revenue TTM | $205M | $214M | |
| Net Income TTM | $-106M | $-75M | |
| P/E | -156.7 | -20.4 | |
| Earnings Yield | -0.64% | -4.9% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $549M | $630M | $838M | $426M | $356M |
| Margine Operativo % | -7.1% | -6.9% | 2.2% | -95.6% | -92.2% |
| Utile netto | $457M | $38M | $101M | $-361M | $-195M |
| EPS Diluito | $0.52 | $0.04 | $0.12 | $-0.43 | $-0.25 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Rapporto corrente | 5.0 | 2.8 | 2.7 | 2.4 | 3.9 |
| Quick Ratio | 4.7 | 2.6 | 2.5 | 2.1 | 3.5 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-79M | $-17M | $187M | $-305M | $-221M |
Proprietari istituzionali (13F) 58 filer · $45.7M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
58
Valore detenuto
$45.7M
Nuove posizioni
9
Posizioni chiuse
4
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 9 (+1 vs trimestre precedente) | 4 (-1 vs trimestre precedente) | 14 (+1 vs trimestre precedente) | 23 (+4 vs trimestre precedente) | +134K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15.823.961 | 1.477.494 | 34,65% | Azioni |
| Allianz Asset Management GmbH | $7.257.739 | 674.511 | 15,89% | Azioni |
| STATE STREET CORP | $3.374.454 | 313.611 | 7,39% | Azioni |
| AIA Group Ltd | $3.133.624 | 291.229 | 6,86% | Azioni |
| M&G PLC | $2.670.701 | 242.791 | 5,85% | Azioni |
| Amundi | $2.199.183 | 204.385 | 4,82% | Azioni |
| JANE STREET GROUP, LLC | $2.092.519 | 194.472 | 4,58% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.400.952 | 130.200 | 3,07% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $1.123.613 | 104.425 | 2,46% | Azioni |
| XY Capital Ltd | $1.120.439 | 104.130 | 2,45% | Azioni |
| Crossmark Global Holdings, Inc. | $913.685 | 84.915 | 2,00% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $680.548 | 63.248 | 1,49% | Azioni |
| UBS Group AG | $475.409 | 44.183 | 1,04% | Azioni |
| Vanguard Personalized Indexing Management, LLC | $458.365 | 42.599 | 1,00% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $419.285 | 38.967 | 0,92% | Azioni |
| CITADEL ADVISORS LLC | $409.536 | 38.061 | 0,90% | Azioni |
| Vident Advisory, LLC | $286.044 | 26.584 | 0,63% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $284.279 | 26.420 | 0,62% | Azioni |
| StoneX Group Inc. | $213.563 | 18.262 | 0,47% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $195.498 | 18.169 | 0,43% | Azioni |
| AMERIPRISE FINANCIAL INC | $169.384 | 15.742 | 0,37% | Azioni |
| Summit Trail Advisors, LLC | $140.848 | 13.090 | 0,31% | Azioni |
| BANK OF AMERICA CORP /DE/ | $134.382 | 12.489 | 0,29% | Azioni |
| XTX Topco Ltd | $133.521 | 12.409 | 0,29% | Azioni |
| Mariner, LLC | $114.659 | 10.656 | 0,25% | Azioni |
| MORGAN STANLEY | $91.944 | 8.545 | 0,20% | Azioni |
| Blue Trust, Inc. | $82.938 | 7.708 | 0,18% | Azioni |
| ROYAL BANK OF CANADA | $58.000 | 5.428 | 0,13% | Azioni |
| Russell Investments Group, Ltd. | $51.633 | 4.821 | 0,11% | Azioni |
| RHUMBLINE ADVISERS | $41.755 | 3.881 | 0,09% | Azioni |
| FMR LLC | $32.097 | 2.983 | 0,07% | Azioni |
| Rockefeller Capital Management L.P. | $11.632 | 1.081 | 0,03% | Azioni |
| Bell Investment Advisors, Inc | $10.922 | 1.015 | 0,02% | Azioni |
| ASSETMARK, INC | $8.737 | 812 | 0,02% | Azioni |
| BlackRock, Inc. | $7.625 | 709 | 0,02% | Azioni |
| JPMORGAN CHASE & CO | $6.405 | 598 | 0,01% | Azioni |
| Silver Grove Financial Group, Inc. | $6.273 | 583 | 0,01% | Azioni |
| US BANCORP \DE\ | $5.950 | 553 | 0,01% | Azioni |
| Arax Advisory Partners | $4.304 | 400 | 0,01% | Azioni |
| North Star Investment Management Corp. | $4.078 | 379 | 0,01% | Azioni |
| SIMPLEX TRADING, LLC | $3.271 | 304 | 0,01% | Azioni |
| FIDUCIARY FINANCIAL ADVISORS | $3.110 | 291 | 0,01% | Azioni |
| OSAIC HOLDINGS, INC. | $2.485 | 231 | 0,01% | Azioni |
| CITIGROUP INC | $2.055 | 191 | 0,00% | Azioni |
| Physician Wealth Advisors, Inc. | $1.550 | 144 | 0,00% | Azioni |
| Cornerstone Financial Management LLC | $1.442 | 134 | 0,00% | Azioni |
| Pinnacle Wealth Planning Services, Inc. | $1.334 | 124 | 0,00% | Azioni |
| EverSource Wealth Advisors, LLC | $990 | 92 | 0,00% | Azioni |
| ACADIAN ASSET MANAGEMENT LLC | $696 | 65.166 | 0,00% | Azioni |
| Larson Financial Group LLC | $387 | 36 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| HUTCHMED Group Investment Limited (formerly known as “Hutchison China MediTech Investment Limited”), HUTCHMED (China) Limited | 07 Febbraio 2022 | · | Deposito iniziale | · | SEC |
| Hutchison China MediTech Investment Limited, HUTCHMED (China) Limited | 16 Agosto 2021 | · | Deposito iniziale | Investimento passivo | SEC |
| General Atlantic Singapore HCM Pte. Ltd., General Atlantic Singapore Fund Pte. Ltd., General Atlantic Singapore Interholdco Ltd., General Atlantic Partners (Bermuda) IV, L.P., General Atlantic Partners (Bermuda) EU, L.P., General Atlantic Partners (Lux) SCSp, L.P., General Atlantic GenPar (Lux) SCSp, L.P., General Atlantic (Lux) S.à r.l., General Atlantic GenPar (Bermuda), L.P., GAP (Bermuda) Limited, General Atlantic LLC, GAP Coinvestments III, LLC, GAP Coinvestments IV, LLC, GAP Coinvestments V, LLC, GAP Coinvestments CDA, L.P. ×2 depositi | 01 Luglio 2021 | · | Deposito iniziale | · | SEC |
| Hutchison Healthcare Holdings Limited, Hutchison Whampoa (China) Limited, CK Hutchison Global Investments Limited, CK Hutchison Holdings Limited ×8 depositi | 30 Giugno 2021 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 4 insider · 4 dirigenti · 2 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO | 20 Maggio 2026 J | · | 0 | 0 | $0 |
| Wei-Guo Su | CEO and CSO | 20 Maggio 2026 J | · | 0 | 0 | $0 |
| Lorenso Chiu | Deputy Chief Financial Officer | 20 Maggio 2026 J | · | 0 | 0 | $0 |
| Charles George Rupert Nixon | Group General Counsel | 20 Maggio 2026 J | · | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
HCM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 28 analisti
COMPRA
Target mediano
$19.50
+37,3%
10 35,7%
Acquisto forte
13 46,4%
Compra
5 17,9%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
14 analisti · 2026-10-02Target medio $22.01 +55,0%
Ora
Prezzo attuale $14.20
Basso$13.60
Media$22.01
Alto$40.40
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HCM | $11.63B | 25.6 | · | 83.3% | 45.7% | · |
| RGC | $8.43B | -23.7 | · | · | -54.8% | · |
Ultime notizie Notizie recenti che menzionano questa società
Intuit (INTU) Launches AI-Native QuickBooks Workforce Platform
Yahoo Finance · 3 mesi, 3 settimane fa
Citi Chiama Cytokinetics, Incorporated (CYTK) un “Top Pick” tra i titoli Biotech Small-to-Mid Cap
Yahoo Finance · 4 mesi fa
Paychex, Inc. (PAYX) È Un Buon Titolo Da Acquistare Ora?
Yahoo Finance · 5 mesi fa
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 20-F depositato Mar 5, 2026